Relevix Pharmaceutical Llp - Due diligence report

A 360° intelligence report on Relevix Pharmaceutical Llp: trust score, financial health, credit view, compliance, directors, growth and dist…

2023-04-28 Tijara, Rajasthan Active
Share
Connect MCP
RP Relevix Pharmaceutical Llp
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Relevix Pharmaceutical Llp — 360° Intelligence Report

Generated from MCA filings & public records
77/100
Trust Score
Low Risk

Relevix Pharmaceutical Llp is assessed as Low Risk with a Trust Score of 77/100. Relevix Pharmaceutical Llp is an active limited liability partnership incorporated in 2023, operating in the Pharma sector. Processed financial statements are not yet available for trend analysis. Based on MCA filings and public records, it currently shows a low compliance risk and an unassessed financial risk profile.

Report generated on 13 Oct 2026 from the latest processed filings. Relevix Pharmaceutical Llp snapshot & full profile →

Financial Health › No Data
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
77/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
75/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreNo Data
N/A
No processed financial statements available yet.
Credit Risk ScoreNo Data
N/A
Financial statements needed for a credit view.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreNo Data
N/A
Needs at least two filed years to measure growth.
Distress ScoreLow Risk
80/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

No processed financials
Financial statements are not yet processed for this company. Trend analysis will appear once filings are available.
04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: N/A No Data
  • Financial statements needed for a credit view.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 75/100 Low Risk
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2024 - filings overdue.
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
HIMANSHU GUPTA 01234567 Director 01/04/2018 6 yrs Approved
UMESH AGGARWAL 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
06

Ownership & Group Intelligence

Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth N/A · Distress 80
Growth signals & trust indicators
Young company (3 years).
Financials unavailable - score leans on compliance and governance signals.
Distress signals & risk flags
Statutory filings appear overdue.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • No financials on record - ask for audited statements.
Banker assessment70/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • No filed financials - rely on banking statements and GST data.
  • No existing security registered - first-charge position available.
  • Compliance record supports lending.
Investor view57/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • No clear growth signals in the filed years.
  • Request management accounts - public filings insufficient.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 5 events
31 Mar 2025
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
28 Apr 2023
Incorporated
Registered with Roc Jaipur
Director appointed
HIMANSHU GUPTA (Designated Partner)
Director appointed
UMESH AGGARWAL (Designated Partner)
10

Key Observations

Auto-generated from the data above
Compliance record is strong - status, filings and flags are clean.
2 active director(s) / partner(s); board looks stable and experienced.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Osher Pharmaceuticals (India) Private Limited U21002RJ2024PTC098769 Alwar, Rajasthan
Pyramid Global Metal Private Limited U51909RJ2022PTC085440 Alwar, Rajasthan
Pingakshaya Aluminium Private Limited U25191RJ1995PTC009924 Alwar, Rajasthan
Deleena Powertrain India Private Limited U29220RJ2022PTC082028 Alwar, Rajasthan
Ayurdata Private Limited U62099RJ2024FTC096975 Alwar, Rajasthan
Sunflag Electric India Private Limited U31900RJ2022PTC082015 Alwar, Rajasthan
Rrl Logistics Private Limited U63011RJ2013PTC043464 Alwar, Rajasthan
Dykaa Smart Solutions Private Limited U32904RJ2024PTC092126 Alwar, Rajasthan
Rashmi Metaimpex Private Limited U27109RJ2012PTC039803 Alwar, Rajasthan
United Trademart Private Limited U51909RJ2013PTC077520 Alwar, Rajasthan
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Relevix Pharmaceutical Llp before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Relevix Pharmaceutical Llp: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score pending financials, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score n/a, margin trends, ownership structure and peer set for Relevix Pharmaceutical Llp - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 77/100, distress signals and MSME payment-delay disclosures - know whether Relevix Pharmaceutical Llp pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Relevix Pharmaceutical Llp - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Relevix Pharmaceutical Llp an active company?

Relevix Pharmaceutical Llp has MCA status “Active” with a compliance score of 75/100 (Low Risk).

Is Relevix Pharmaceutical Llp financially healthy?

Processed financial statements are not yet available for Relevix Pharmaceutical Llp, so its financial health is unassessed.

Should I do business with Relevix Pharmaceutical Llp?

Its overall Trust Score is 77/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Relevix Pharmaceutical Llp?

See the directors and ownership sections above for board and shareholding detail. 2 active director(s) are on record.

Does Relevix Pharmaceutical Llp have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Relevix Pharmaceutical Llp up to date with its ROC filings?

Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 75/100 (Low Risk).

Is it risky to lend to Relevix Pharmaceutical Llp?

Filed financial statements are needed for a credit view - ask the company for audited statements and bank statements.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.